ERENUMAB
UNII I5I8VB78VT

Substance Identification & Data

This profile provides standardized clinical and technical data for Erenumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I5I8VB78VT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1582205-90-0 and the RxNorm Concept ID (RxCUI) 2045613. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

I5I8VB78VT

CAS Registry Number

1582205-90-0

RxNorm Concept ID

2045613

Detailed Substance Profile

Preferred Name

ERENUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

I5I8VB78VT

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C169958

National Cancer Institute reference terminology for clinical and research data.

INN ID

10296

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Erenumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ERENUMAB

ERENUMAB-AOOE

Common Names & Synonyms

ERENUMAB [INN]

ERENUMAB [JAN]

ERENUMAB [MI]

ERENUMAB [USAN]

ERENUMAB [WHO-DD]

ERENUMAB AOOE [WHO-DD]

ERENUMAB-AOOE [PURPLE BOOK CDER]

IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER